KENNEY CHRISTOPHER JOHN Insider Trading Activity

Average Profitability
29.65%
Insider Buys Quantity
1
Insider Buys Sum
$40,334.00
Insider Sells Quantity
1
Insider Sells Sum
$24,507.00

Insider Activity of KENNEY CHRISTOPHER JOHN

According to the SEC Form 4 filings, KENNEY CHRISTOPHER JOHN, being in a position of

  1. Chief Medical Officer at Xenon Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11249 shares for $670,256,
    over all time since 2022-01-21, has bought 1400 shares for $40,334, and sold 11949 shares for $694,763.

Biography of KENNEY CHRISTOPHER JOHN

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $670,2563100

Comparison of Insiders on Amount of Buys and Sells

2026-08-28SaleXenon Pharmaceuticals Inc.
XENE
Chief Medical Officer
7,068
0.0071%
$60.25$425,829-37.53%
2026-03-13SaleXenon Pharmaceuticals Inc.
XENE
Chief Medical Officer
1,410
0.0017%
$55.23$77,867+1.43%
2026-03-10SaleXenon Pharmaceuticals Inc.
XENE
Chief Medical Officer
2,771
0.0034%
$60.11$166,559-7.54%
2023-03-24SaleXenon Pharmaceuticals Inc.
XENE
Chief Medical Officer
700
0.0011%
$35.01$24,507+10.88%
2022-01-21PurchaseXenon Pharmaceuticals Inc.
XENE
Chief Medical Officer
1,400
0.0028%
$28.81$40,334+29.65%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.